All In Biotech

Drug Trial Radar · NCT03924414

Trial of Parkinson's And Zoledronic Acid

TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,721 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,721

Actual

Start

Nov 15, 2019

Primary completion

Feb 28, 2026

Study completion Feb 28, 2026

Sponsor

Lead sponsor
California Pacific Medical Center Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Aging (NIA); University of California, San Francisco; Duke University; University of Pittsburgh; Parkinson's Foundation
First posted
Apr 23, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-up. A total of 2650 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and study investigators will be blinded to assigned study treatment. This trial is funded by the National Institute of Aging.

Conditions

  • Parkinson Disease
  • Osteoporosis
  • Parkinsonism
  • Parkinson's Disease and Parkinsonism
  • Atypical Parkinsonism
  • Progressive Supranuclear Palsy
  • Multiple System Atrophy
  • Vascular Parkinsonism
  • Dementia With Lewy Bodies

Interventions

  • Zoledronic Acid 5Mg/Bag 100Ml InjDrug

    Zoledronic acid 5mg/100 ml IV infusion: Zoledronic acid-5 mg (ZA) is an FDA approved therapy for men and postmenopausal women for the treatment and prevention of osteoporosis.

  • PlaceboOther

    Normal Saline 100 ml (placebo) IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Clinical FracturesTime frame: 2 years
  2. Number of Participants with Clinical FracturesTime frame: 5 years

Locations

77 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • Washington Regional Medical Center

    Fayetteville, Arkansas

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Sutter Health

    Berkeley, California

  • Parkinson's and Movement Disorder Institute

    Fountain Valley, California

  • University of California, Irvine

    Irvine, California

  • Loma Linda University

    Loma Linda, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • University of California, Los Angeles

    Los Angeles, California

  • Valley Parkinson Clinic

    Los Gatos, California

  • Parkinson's Disease and Movement Disorder Center of Silicon Valley

    Palo Alto, California

  • University of California, Riverside

    Riverside, California

  • Sutter Health

    Sacramento, California

  • University of California, Davis

    Sacramento, California

  • University of California, San Francisco

    San Francisco, California

  • University of Colorado, Denver

    Aurora, Colorado

  • St. Mary's Medical Center

    Grand Junction, Colorado

  • University of Connecticut

    Farmington, Connecticut

  • University of Connecticut

    Farmington, Connecticut

  • Hartford Healthcare

    Hartford, Connecticut

  • University of Florida

    Gainesville, Florida

  • Mayo Clinic

    Jacksonville, Florida

  • Parkinson's Foundation

    Miami, Florida

  • University of Miami

    Miami, Florida

  • Morehouse School of Medicine

    Atlanta, Georgia

  • Emory University School of Medicine

    Atlanta, Georgia

  • Augusta University

    Augusta, Georgia

  • Queens Medical Center

    Honolulu, Hawaii

  • Northwestern Medicine

    Chicago, Illinois

  • Cook County Health & Hospitals System

    Chicago, Illinois

  • Rush University

    Chicago, Illinois

  • University of Chicago

    Chicago, Illinois

  • Loyola University

    Chicago, Illinois

  • Edward Hines, Jr. VA Hospital

    Hines, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • University of Kentucky

    Lexington, Kentucky

  • Ochsner Health System

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • Boston University

    Boston, Massachusetts

Showing 40 of 77 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.